A multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor…
Currently Recruiting
A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of…
Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Lead PI: Professor Craig Anderson Status: Recruiting, Site selection No. of Patients Currently Recruited: 18 …
Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study (PACIFIC-STROKE)…
A Prospective multicentre, phase 2b randomised controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality…
QUALITY IN ACUTE STROKE CARE (QASC) AUSTRALIA TRIAL Principal Investigator: Prof Sandy Middleton The Quality in Acute Stroke Care (QASC)…
Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke ReCAPS: Recovery-focused Community support to Avoid readmissions and improve Participation…
Safety and Tolerability of AZD6482 in Reperfusion for Stroke (STARS) Study Lead PI: Dr Candice Delcourt Status: Recruiting No. of…
Stopping haemorrhage with Tranexamic acid for hyperacute Onset Presentation including Mobile Stroke Units Lead PI: Prof Stephen Davis, Prof Geoff Donnan,…
Trial of Advance CT Imaging and Combined Education Support for stroke patient access to endovascular therapy (EVT) using a hub…